| Chimeric Therapeutics Limited (CHM) ORDINARY FULLY PAID |
Health Care |
$3 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
28 Jan 2026 9:42AM |
$0.003 |
$0.002 |
fallen by
20%
|
|
CHM - Price-sensitive ASX Announcement
Full Release
Key Points
- Chimeric Therapeutics had $2.50 million in cash at 31 December 2025.
- Received $4.50 million from R&D tax incentive.
- CHM CDH17 trial fully funded through Phase 1 with $8.4 million in funding.
- 75% disease control achieved in CHM CDH17 trial.
- CHM CDH17 CAR-T received FDA Orphan Drug Designation for gastric cancer.
- CORE-NK Phase 1b trial in AML showed additional complete responses.
- Implemented strategic reset to reduce costs and focus on key clinical assets.
- Resignation of Chief Medical Officer and board refreshment planned.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Thorney Opportunities Ltd (TOP) ORDINARY FULLY PAID |
Financials |
$90 |
Update - Notification of buy-back - TOP
|
28 Jan 2026 9:42AM |
$0.680 |
$0.530 |
fallen by
22.06%
|
|
| Thrive Tribe Technologies Limited (1TT) ORDINARY FULLY PAID |
Information Technology |
$2 |
Application for quotation of securities - 1TT
|
28 Jan 2026 9:42AM |
$0.002 |
$0.001 |
fallen by
33.33%
|
|
| PainChek Ltd (PCK) ORDINARY FULLY PAID |
Health Care |
$38 |
Quarterly update & Appendix 4C webinar
|
28 Jan 2026 9:41AM |
$0.270 |
$0.180 |
fallen by
33.33%
|
|
| Meteoric Resources NL (MEI) ORDINARY FULLY PAID |
Materials |
$450 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
28 Jan 2026 9:40AM |
$0.255 |
$0.170 |
fallen by
33.33%
|
|
MEI - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash outflow from operating activities: $8.417 million
- Investing activities expenditure: $3.229 million
- Equity securities issued: $42.5 million
- Positive cash flow from financing: $39.889 million
- End of period cash equivalents: $32.387 million
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Patriot Resources Limited (PAT) ORDINARY FULLY PAID |
Materials |
$19 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
28 Jan 2026 9:40AM |
$0.060 |
$0.071 |
risen by
18.33%
|
|
PAT - Price-sensitive ASX Announcement
Full Release
Key Points
- Entry into a binding agreement to acquire 100% of the high-grade Tassa Silver-Gold deposit in Peru.
- Completion of a $4.25 million capital raising to fund the Tassa acquisition and other projects.
- Significant expansion of polymetallic mineralized footprint at the Kitumba Project in Zambia.
- Completion of high-resolution ground magnetics and IP surveys at Target B1.
- Consolidation of land tenure in the Mumbwa District through acquisition of Mirkal and Chimban licences.
- Cash and cash equivalents increased to $2,196,000 at the end of the reporting period.
- Net cash used in operating activities totaled $488,000 for the quarter.
- No mining production or development activities reported during the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| 5E Advanced Materials Inc. (5EA) CHESS DEPOSITARY INTERESTS 10:1 |
Materials |
$3 |
Suspension from Quotation
|
28 Jan 2026 9:40AM |
$0.530 |
$0.185 |
fallen by
65.09%
|
|
5EA - Price-sensitive ASX Announcement
Full Release
Key Points
- 5E Advanced Materials, Inc. requested suspension from quotation on ASX.
- Suspension is pending an announcement about a proposed U.S. public offering.
- Effective immediately and will last until February 2, 2026, or upon earlier announcement.
- The request was made under ASX Listing Rule 17.2.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Regener8 Resources NL (R8R) ORDINARY FULLY PAID |
Materials |
$6 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
28 Jan 2026 9:39AM |
$0.125 |
$0.150 |
risen by
20%
|
|
R8R - Price-sensitive ASX Announcement
Full Release
Key Points
- Regener8 Resources NL holds multiple tenements with varied expiry dates.
- Exploration activities at North Achilles project show promising multi-element anomalies.
- The company has a track record of successfully raising funds to support its operations.
- Expenditure on exploration and evaluation during the quarter was $65,000.
- Payment to related parties during the quarter was $57,000.
- The company's annual general meeting results were positive.
- Cash and cash equivalents at quarter end were $235,000.
- Estimated quarters of funding available is 1.4 quarters based on cash flow analysis.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EV Resources Limited (EVR) ORDINARY FULLY PAID |
Materials |
$27 |
High-Grade Critical Metals Results Enhance US Pipeline
|
28 Jan 2026 9:38AM |
$0.010 |
$0.009 |
fallen by
10%
|
|
EVR - Price-sensitive ASX Announcement
Full Release
Key Points
- High-grade assay results from Milton Antimony Project.
- Significant findings include 9.82% Sb, 24.00% Cu, and 434ppm Ag.
- The project suggests a prospective polymetallic vein system.
- Proximity to Dollar Project and US Army Critical Metals Depot.
- Plans for soil sampling and geological mapping in March/April 2026.
- Alignment with US legislation for domestic critical metals supply.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Viridis Mining and Minerals Limited (VMM) ORDINARY FULLY PAID |
Materials |
$268 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
28 Jan 2026 9:38AM |
$1.980 |
$2.070 |
risen by
4.55%
|
|
VMM - Price-sensitive ASX Announcement
Full Release
Key Points
- Landmark Environmental Approval granted for Colossus Project.
- Received COPAM approval, enhancing project's development timeline.
- Non-binding Letter of Support from Bpifrance for project financing.
- Net cash inflow from financing activities: $8,625,000 for the quarter.
- Continued strategic landholding expansion in Minas Gerais, Brazil.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Patrys Limited (PAB) ORDINARY FULLY PAID |
Health Care |
$14 |
Investor Presentation
|
28 Jan 2026 9:37AM |
$0.030 |
$0.026 |
fallen by
13.33%
|
|
PAB - Price-sensitive ASX Announcement
Full Release
Key Points
- Patrys Limited is developing AQS, an injectable quetiapine formulation.
- AQS targets unmet needs in delirium treatment, prevalent in ICU and aged care.
- Current treatments are often off-label with significant limitations.
- AQS offers rapid onset, high bioavailability, and customizable dosing.
- The reformulation uses regulatory pathways for faster market approval.
- Intellectual property protection includes a provisional patent.
- Strategic partnerships sought with companies in CNS and hospital markets.
- Market opportunity estimated at over US$2 billion annually.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lowell Resources Fund (LRT) ORDINARY UNITS FULLY PAID |
Financials |
$104 |
LRT NAV Estimate - 23 January 2026
|
28 Jan 2026 9:37AM |
$2.720 |
$2.500 |
fallen by
8.09%
|
|
| Patrys Limited (PAB) ORDINARY FULLY PAID |
Health Care |
$14 |
Completion of Acquisition and Board Appointments
|
28 Jan 2026 9:36AM |
$0.030 |
$0.026 |
fallen by
13.33%
|
|
PAB - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of Reliis Pty Ltd acquisition by Patrys Limited.
- Reliis becomes a wholly-owned subsidiary of Patrys.
- RLS-2201 injectable quetiapine program added to Patrys’ pipeline.
- Appointment of Leanne Kite and Dino Cercarelli as Non-Executive Directors.
- Issuance of Consideration Securities as per acquisition agreement.
- RLS-2201 targets delirium management in acute-care settings.
- The acquisition aligns with Patrys’ strategy to expand its clinical-stage pipeline.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Barton Gold Holdings Limited (BGD) ORDINARY FULLY PAID |
Materials |
$236 |
Notification of cessation of securities - BGD
|
28 Jan 2026 9:36AM |
$1.265 |
$0.990 |
fallen by
21.74%
|
|
| Thorney Technologies Ltd (TEK) ORDINARY FULLY PAID |
Financials |
$37 |
Update - Notification of buy-back - TEK
|
28 Jan 2026 9:36AM |
$0.130 |
$0.099 |
fallen by
23.85%
|
|
| Premier1 Lithium Limited (PLC) ORDINARY FULLY PAID |
Materials |
$10 |
Trading Halt
|
28 Jan 2026 9:35AM |
$0.008 |
$0.011 |
risen by
37.50%
|
|
PLC - Price-sensitive ASX Announcement
Full Release
Key Points
- Premier1 Lithium Limited requested a trading halt.
- The halt will last up to two business days.
- The halt is pending an announcement regarding capital raising and acquisition.
- Trading halt will stay until the release of the announcement or normal trading on 30 January 2026.
- The company is not aware of any reasons against the halt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| CGN Resources Limited (CGR) ORDINARY FULLY PAID |
Materials |
$8 |
Proposed issue of securities - CGR
|
28 Jan 2026 9:35AM |
$0.095 |
$0.074 |
fallen by
22.11%
|
|
| Yojee Limited (YOJ) ORDINARY FULLY PAID |
Information Technology |
$100 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
28 Jan 2026 9:35AM |
$0.350 |
$0.280 |
fallen by
20%
|
|
YOJ - Price-sensitive ASX Announcement
Full Release
Key Points
- Strong cash reserves with a closing cash position of $6.18 million as of 31 December 2025 and no debt.
- Achieved a 23% reduction in net operating cash outflows, reducing from $793k to $607k.
- Continued live environment testing of the MOSAIC platform with foundational freight forwarding and customs broker partners.
- New contracts signed with Australian TCMS customers, including Fracht Australia and Road Feeder Services.
- Operational rollout for Röhlig Logistics extended to Australia, New Zealand, and Southeast Asia.
- Strengthened leadership with key appointments including Robert Cotter as Chief Growth Officer and Frank Guerra as Non-Executive Director.
- Invested $568k in the development of the MOSAIC platform.
- Cash receipts for the quarter were $90k.
- Payments to related parties totaled $96k, comprising Director fees and salaries.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Albright Metals Ltd (ABR) ORDINARY FULLY PAID |
Materials |
$4 |
High-Grade Gold Results for Golden Pike Project
|
28 Jan 2026 9:35AM |
$0.006 |
$0.003 |
fallen by
50%
|
|
ABR - Price-sensitive ASX Announcement
Full Release
Key Points
- First assays received from 2025 drilling at Vail Road Gold Deposit.
- Significant intercepts include 6.27m at 33.74 g/t Au.
- Confirmation of high-grade nature supports rapid progression to JORC compliance.
- Infill drilling in Parallel Zone confirms continuity of mineralized vein.
- Further assay results pending within coming weeks.
- Golden Pike Project located in New Brunswick, Canada.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rokeby Resources Limited (RKB) ORDINARY FULLY PAID |
Materials |
$6 |
Hurricane Soil Sampling
|
28 Jan 2026 9:35AM |
$0.005 |
$0.004 |
fallen by
22.22%
|
|
| Evergold Minerals Limited (EG1) ORDINARY FULLY PAID |
Materials |
$10 |
EG1 acquires Randwick tenements in Leonora Goldfields, WA
|
28 Jan 2026 9:34AM |
$0.050 |
$0.029 |
fallen by
42%
|
|
EG1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Evergold acquires 100% of Randwick Tenements
- Acquisition includes two mining leases and ten prospecting licenses
- Covers approximately 1,800 hectares in Leonora Goldfields
- Consolidates position in Mertondale Goldfield
- Upfront cost of AUD 250,000 in shares
- Contingent cash payment upon future resource announcement
- Immediate exploration access granted
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WOTSO (WOT) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$108 |
Exercise of Call Option for Sale of Yandina Property
|
28 Jan 2026 9:34AM |
$0.520 |
$0.670 |
risen by
28.85%
|
|
| Xamble Group Limited (XGL) CHESS DEPOSITARY INTERESTS 1:1 |
Communication Services |
$5 |
Xamble Unveils AI Agent to Scale Creator Growth
|
28 Jan 2026 9:33AM |
$0.015 |
$0.012 |
fallen by
20%
|
|
| Oncosil Medical Limited (OSL) ORDINARY FULLY PAID |
Health Care |
$15 |
TRIPP-FFX Trial Completes Last Patient Last Visit
|
28 Jan 2026 9:32AM |
$0.840 |
$0.490 |
fallen by
41.67%
|
|
| Gale Pacific Limited (GAP) ORDINARY FULLY PAID |
Consumer Discretionary |
$23 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
28 Jan 2026 9:32AM |
$0.094 |
$0.080 |
fallen by
14.89%
|
|
GAP - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly Activity Report and Appendix 4C Cash Flow Report released for Q2 FY26.
- Achieved EBITDA of $4.4 million for Q2 and $5.7 million for H1 FY26.
- Positive operating cash flow of $15.3 million in Q2, with improved net cash position of $1.7 million.
- Revenue declined by 9% year-on-year due to tough US trading conditions and slow Australian retail season start.
- Australian retail margins improved by 3.8%, US retail margins remained resilient.
- Established new sales team in Thailand and reduced overheads by $3.8 million or 12%.
- Progress in digital strategy and diversification of manufacturing footprint.
- Focus on productivity, efficiency, and strategic execution going forward.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
